Owens & Minor, Inc. (NYSE:OMI) Shares Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. raised its stake in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 31.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 192,492 shares of the company's stock after purchasing an additional 45,576 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.25% of Owens & Minor worth $2,515,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. grew its stake in Owens & Minor by 57.4% in the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock valued at $57,000 after buying an additional 1,600 shares during the last quarter. KBC Group NV raised its position in Owens & Minor by 98.2% in the fourth quarter. KBC Group NV now owns 4,434 shares of the company's stock valued at $58,000 after purchasing an additional 2,197 shares during the last quarter. Inspire Advisors LLC boosted its stake in shares of Owens & Minor by 11.2% in the 4th quarter. Inspire Advisors LLC now owns 15,350 shares of the company's stock valued at $201,000 after purchasing an additional 1,548 shares during the last quarter. KLP Kapitalforvaltning AS bought a new position in Owens & Minor during the fourth quarter worth $256,000. Finally, Wealthfront Advisers LLC acquired a new position in Owens & Minor during the fourth quarter worth $257,000. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, major shareholder Coliseum Capital Management, L bought 354,901 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average price of $9.19 per share, with a total value of $3,261,540.19. Following the purchase, the insider now owns 9,824,599 shares in the company, valued at approximately $90,288,064.81. The trade was a 3.75 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last 90 days, insiders have bought 2,718,412 shares of company stock valued at $24,495,308. 3.69% of the stock is currently owned by company insiders.

Owens & Minor Stock Performance

Shares of NYSE OMI traded up $0.31 during midday trading on Wednesday, reaching $6.78. 171,971 shares of the stock were exchanged, compared to its average volume of 1,627,262. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm has a 50-day simple moving average of $8.21 and a two-hundred day simple moving average of $11.38. Owens & Minor, Inc. has a twelve month low of $6.07 and a twelve month high of $25.72. The firm has a market cap of $523.79 million, a price-to-earnings ratio of -10.43, a PEG ratio of 0.20 and a beta of 1.02.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.02. The company had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm's revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.69 EPS. As a group, analysts anticipate that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its board has authorized a share buyback program on Friday, February 28th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 13.6% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on OMI shares. Robert W. Baird raised their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. JPMorgan Chase & Co. decreased their target price on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating on the stock in a research note on Monday, March 10th. Citigroup reduced their price target on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, April 17th. Finally, UBS Group dropped their price target on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Owens & Minor currently has an average rating of "Hold" and an average target price of $12.50.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.